Antofagasta PLC (ANTO)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 3,048.00 |
|---|---|
| 52-week range | 2,496.00 – 4,475.00 |
| Return, 1 month / 3 months | −18.6% / −15.8% |
| Return, 1 year / 3 years | +15.4% / +135.1% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 51.7% |
| Worst drawdown (1 year) | -32.1% |
| Average daily value traded | 4,007.98M GBX |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Antofagasta is a mining company based in Chile that focuses on copper production, with molybdenum and gold recovered as by-products. It runs open-pit mines in the north of the country and ships concentrate and cathodes to customers around the world. The company also operates a railway that carries freight, including minerals, in northern Chile. Its activities span mining, processing and transport, and its main market is the global copper trade.
Antofagasta PLC trades under the code ANTO on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Antofagasta PLC (ANTO) trades on the London Exchange in UK. It last closed at GBX 3,048.00 on 23 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,411 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.4% and over the last three months it fell 15.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.0% | ||
| From 52-week high | -31.6% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.8% | ||
| 6-month return | -20.4% | ||
| 12-month return, skipping the last month | 41.8% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.1% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 4,007.98M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −10.4% |
|---|---|
| 1 month | −18.6% |
| 3 months | −15.8% |
| 6 months | −20.4% |
| 1 year | +15.4% |
| 3 years | +135.1% |
| 5 years | +112.3% |
Signals
| 50-day / 200-day average | 3,701.86 / 3,760.70 |
|---|---|
| Golden / death cross (60 days) | Death, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 164.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | USD 0.2258 |
| 16 Apr 2026 | USD 0.3558 |
| 4 Sep 2025 | USD 0.1226 |
| 17 Apr 2025 | USD 0.1763 |
| 5 Sep 2024 | USD 0.0607 |
| 18 Apr 2024 | USD 0.1952 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.